Please assess the completion status of the following clinical trial:

Trial Title: Dexmedetomidine and Melatonin for Sleep Induction for EEG in Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age between 1 and 20 years~* Referral for EEG in sleep~* Children/young adults whose parents/caregivers were informed about the aims of the study and have signed the Informed consent form~Exclusion Criteria:~* Children that were unable to follow the study protocol were excluded during the study

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 20 Years
- Healthy Volunteers: f

Study Arms:
- Melatonin peroral (Type: EXPERIMENTAL): 0,1mg/kg melatonin will be given in the form of a syrup to the participant before EEG and vital functions monitoring
- Dexmedetomidine intranasally (Type: EXPERIMENTAL): 3 mcg/kg of dexmedetomidine in the form of a nasal spray will be given to the participant before EEG and vital functions monitoring
- Dexmedetomidine sublingually (Type: EXPERIMENTAL): 3 mcg/kg of dexmedetomidine will be given to the participant sublingually before EEG and vital functions monitoring

Based on this trial design, predict the completion outcome and termination type (if applicable).